Atopic dermatitis topical therapies comments
Comment by May 30!
Comment by May 30, 2022 for your feedback to be reviewed by the guideline development workgroup.
The AAD is seeking member comments on draft clinical practice guidelines on the management of atopic dermatitis (AD) with topical therapies in adults. These guidelines appraise evidence of the efficacy and safety of topical treatments for AD. The development of these guidelines followed a systematic approach and recommendations were formed by a guideline work group that includes experts in AD management from multiple clinical settings, a methodologist, and a patient representative. The comment period is open to all AAD members and comments are being accepted through May 30, 2022. Feedback received will be provided to the guideline development work group for review.
Draft documents for review
There are two PDFs available for review.
The first is the draft guideline.
The second is the supplement of appendices.
View the Academy guidelines disclaimer.
